• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

How to Approach Severe AD With Combination Therapy

Author(s):

Matthew Zirwas, MD

A panelist discusses how combining different therapeutic approaches, such as topical agents with systemic medications, can provide optimal control for patients with severe atopic dermatitis while managing both acute flares and long-term disease maintenance.

Current Time 0:00
Duration 5:50
Loaded: 0%
Stream Type LIVE
Remaining Time 5:50
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Related Videos
    1 expert in this video
    Laboratory Monitoring for JAK Inhibitors and Key Takeaways
    1 expert in this video
    Options for Eyebrow and Eyelash Regrowth in a 32-Year-Old Female With Alopecia Areata
    4 experts are featured in this series.
    Efficacy, Safety, and Role in Therapy of JAK Inhibitors for Atopic Dermatitis
    4 experts are featured in this series.
    The Impact of JAK Selectivity in Atopic Dermatitis Treatment
    1 expert is featured in this series.
    Recapping the Evolving Treatment Landscape for Atopic Dermatitis
    1 expert in this video
    Sunscreen Ingredients for UV and Visible Light Protection
    1 expert in this video
    The Solar Spectrum and Impact on Skin Health
    1 expert in this video
    Discussing Efficacy and Safety of JAK Inhibitors With Patients and Caregivers
    1 expert in this video
    Patient Considerations for Selecting Treatment for a 16-Year-Old Male With Severe Alopecia Areata
    Future Directions for Pediatric Atopic Dermatitis Management and Research
    Future Directions for Pediatric Atopic Dermatitis Management and Research
    Related Content
    Improving Social Determinants of Health Essential for Better AD Outcomes in Pediatric Patients of Color
    March 14th 2025

    Improving Social Determinants of Health Essential for Better AD Outcomes in Pediatric Patients of Color

    The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
    August 2nd 2024

    The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

    Dupilumab Reduces Levels of Immunoglobulin E in Pediatric Patients with Moderate-to-Severe AD
    March 12th 2025

    Dupilumab Reduces Levels of Immunoglobulin E in Pediatric Patients with Moderate-to-Severe AD

    The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
    July 1st 2024

    The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

    Lebrikizumab Shows 3-Year Sustained Efficacy in AD
    March 11th 2025

    Lebrikizumab Shows 3-Year Sustained Efficacy in AD

    Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025
    March 11th 2025

    Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025

    © 2025 MJH Life Sciences

    All rights reserved.